Omega Healthcare Investors, Inc. (NYSE:OHI – Get Free Report) COO Daniel J. Booth sold 56,725 shares of the business’s stock in a transaction dated Friday, September 27th. The shares were sold at an average price of $40.25, for a total value of $2,283,181.25. Following the completion of the transaction, the chief operating officer now owns 100,000 shares in the company, valued at $4,025,000. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link.
Omega Healthcare Investors Trading Down 0.8 %
Shares of NYSE:OHI traded down $0.32 during trading on Tuesday, hitting $40.39. The company had a trading volume of 1,280,184 shares, compared to its average volume of 1,687,011. The stock has a market cap of $9.98 billion, a price-to-earnings ratio of 36.65, a price-to-earnings-growth ratio of 1.32 and a beta of 1.00. The company has a debt-to-equity ratio of 1.19, a current ratio of 5.79 and a quick ratio of 5.79. The company has a fifty day simple moving average of $38.81 and a two-hundred day simple moving average of $34.40. Omega Healthcare Investors, Inc. has a one year low of $27.53 and a one year high of $41.53.
Omega Healthcare Investors (NYSE:OHI – Get Free Report) last issued its quarterly earnings results on Thursday, August 1st. The real estate investment trust reported $0.45 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.65 by ($0.20). Omega Healthcare Investors had a return on equity of 8.61% and a net margin of 33.52%. The company had revenue of $252.70 million during the quarter, compared to the consensus estimate of $205.92 million. During the same quarter in the prior year, the business earned $0.74 earnings per share. The firm’s quarterly revenue was up 17.5% compared to the same quarter last year. As a group, equities analysts forecast that Omega Healthcare Investors, Inc. will post 2.69 earnings per share for the current year.
Omega Healthcare Investors Announces Dividend
Wall Street Analysts Forecast Growth
Several brokerages recently issued reports on OHI. Scotiabank lifted their target price on Omega Healthcare Investors from $33.00 to $39.00 and gave the company a “sector perform” rating in a research note on Monday, August 26th. Mizuho downgraded shares of Omega Healthcare Investors from an “outperform” rating to a “neutral” rating and lifted their price target for the company from $34.00 to $35.00 in a report on Thursday, July 25th. Wells Fargo & Company restated an “overweight” rating and set a $43.00 price target (up previously from $40.00) on shares of Omega Healthcare Investors in a report on Tuesday. Finally, Truist Financial upped their price objective on Omega Healthcare Investors from $33.00 to $39.00 and gave the stock a “hold” rating in a report on Wednesday, September 4th. Eight equities research analysts have rated the stock with a hold rating and three have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, Omega Healthcare Investors currently has an average rating of “Hold” and an average price target of $35.78.
View Our Latest Stock Report on OHI
Institutional Trading of Omega Healthcare Investors
A number of hedge funds and other institutional investors have recently added to or reduced their stakes in OHI. Vanguard Group Inc. increased its stake in Omega Healthcare Investors by 0.5% in the first quarter. Vanguard Group Inc. now owns 35,379,787 shares of the real estate investment trust’s stock worth $1,120,478,000 after purchasing an additional 165,105 shares during the period. Dimensional Fund Advisors LP increased its stake in Omega Healthcare Investors by 7.9% in the 2nd quarter. Dimensional Fund Advisors LP now owns 3,732,390 shares of the real estate investment trust’s stock worth $127,831,000 after buying an additional 272,299 shares during the period. Centersquare Investment Management LLC lifted its holdings in Omega Healthcare Investors by 36.6% during the 4th quarter. Centersquare Investment Management LLC now owns 3,585,255 shares of the real estate investment trust’s stock valued at $109,924,000 after buying an additional 960,997 shares in the last quarter. Bank of New York Mellon Corp boosted its position in Omega Healthcare Investors by 4.6% in the 2nd quarter. Bank of New York Mellon Corp now owns 3,240,025 shares of the real estate investment trust’s stock valued at $110,971,000 after buying an additional 143,521 shares during the period. Finally, LSV Asset Management grew its stake in Omega Healthcare Investors by 0.7% in the 2nd quarter. LSV Asset Management now owns 1,968,200 shares of the real estate investment trust’s stock worth $67,411,000 after acquiring an additional 14,000 shares in the last quarter. 65.25% of the stock is owned by hedge funds and other institutional investors.
Omega Healthcare Investors Company Profile
Omega is a REIT that invests in the long-term healthcare industry, primarily in skilled nursing and assisted living facilities. Its portfolio of assets is operated by a diverse group of healthcare companies, predominantly in a triple-net lease structure. The assets span all regions within the U.S., as well as in the U.K.
See Also
- Five stocks we like better than Omega Healthcare Investors
- Asset Allocation: The Key to a Successful Portfolio. Are You Paying Attention to Yours?
- Why Lennar Stock Could Be the Best Play in the Housing Market
- Earnings Per Share Calculator: How to Calculate EPS
- 2 Energy Stocks Fueling the AI Datacenter Boom
- How to Use the MarketBeat Excel Dividend Calculator
- Will Marinus Pharmaceuticals Be the Next Big Winner in Biotech?
Receive News & Ratings for Omega Healthcare Investors Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Omega Healthcare Investors and related companies with MarketBeat.com's FREE daily email newsletter.